title: [Transarterial therapy for hepatocellular cancer].
abstract: OBJECTIVE
  To estimate treatment of patients with hepatocellular cancer after transarterial chemoembolization as independent curative method, "bridge" to liver transplantation and in the context of combined therapy.
  
  
  METHODS
  We presented an experience of transarterial chemoembolization in treatment of 29 patients with hepatocellular cancer. Curative procedures were performed in the context of independent therapy, "bridge" to liver transplantation and combined treatment. It was performed 48 procedures in all. 44.9% of patients underwent one and two procedures, 10.2%--three performances. Mean interval between procedures was 76.2±116.2 days (range 8-139 days).
  
  
  RESULTS
  Post-embolization syndrome including fervescence, nausea and pain was observed in 24.1% after 1st stage, in 50% and 33.3% after 2nd and 3rd stages respectively. Mean time of expectation of liver transplantation in bridge therapy group was 8.5±6.8 months (range 1-20 months). Median survival after transarterial chemoembolization in monotherapy group was 9 months.
authors.affiliation: Acad. B.V. Petrovskiy Russian Research Center for Surgery, Moscow.
authors.forename: D A
authors.initials: DA
authors.lastname: Chekunov
authors.affiliation: Acad. B.V. Petrovskiy Russian Research Center for Surgery, Moscow.
authors.forename: R S
authors.initials: RS
authors.lastname: Polyakov
authors.affiliation: Acad. B.V. Petrovskiy Russian Research Center for Surgery, Moscow.
authors.forename: N N
authors.initials: NN
authors.lastname: Bagment
authors.affiliation: acad. V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Health Ministry of the Russian Federation, Moscow, Russia.
authors.forename: Ya G
authors.initials: YG
authors.lastname: Moysyuk
authors.affiliation: Acad. B.V. Petrovskiy Russian Research Center for Surgery, Moscow.
authors.forename: D N
authors.initials: DN
authors.lastname: Fedorov
authors.affiliation: Acad. B.V. Petrovskiy Russian Research Center for Surgery, Moscow.
authors.forename: O G
authors.initials: OG
authors.lastname: Skipenko
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D002406:Catheterization, Peripheral / Q000379:methods*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult